Company Brief
Mind Cure Health (CA:MCUR / US:MCURF) is a diversified life sciences company combining drug development, drug synthesis, drug manufacturing and IP development in the psychedelics space to provide investors with multiple avenues to add value.
MINDCURE has assembled a deep management team,
led by CEO and President Kelsey Ramsden, twice named Canada’s female entrepreneur of the year. The Company is well-capitalized to execute on operations, having raised >CAD$25 million.
MINDCURE is currently
aggressively commercializing its iSTRYM digital therapeutics platform. As a universal healthcare platform, the Company is eyeing not only broad penetration in mental health clinics (in the U.S., Canada and Europe) but also the use of iSTRYM as a platform in general healthcare.
https://www.youtube.com/watch?v=rRjd4EUudBE
52-Week Range:
CAD$0.21 - $1.09
Current Outstanding:
93.76 million
Fully Diluted:
69,767,000
Market Cap:
CAD$20 million
52-Week Range:
CAD$0.21 - $1.09
Current Outstanding:
93.76 million
Fully Diluted:
69,767,000
Market Cap:
CAD$20 million